Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Holles Natalie C. Create: Alert

All | News | Filings
Date FiledTypeDescription
03/08/2023 4 Holles Natalie C. (CEO) has filed a Form 4 on Third Harmonic Bio, Inc.
Txns: Disposed/sold 467,634 options to buy @ $9.22, valued at $4.3M
Granted 467,634 options to buy @ $4.2, valued at $2M
Disposed/sold 205,000 options to buy @ $18.4, valued at $3.8M
Granted 205,000 options to buy @ $4.2, valued at $861k
Granted 360,000 options to buy @ $4.2, valued at $1.5M
10/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/14/2022 3 Holles Natalie C. (CEO) has filed a Form 3 on Third Harmonic Bio, Inc.
06/23/2022 4 Holles Natalie C. (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.
Txns: Granted 28,700 options to buy @ $16.29, valued at $467.5k
05/13/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/14/2021 4 Holles Natalie C. (Director) has filed a Form 4 on Allakos Inc.
Txns: Granted 7,700 options to buy @ $99.83, valued at $768.7k
05/26/2021 3 Form 3 - Initial statement of beneficial ownership of securities:
05/13/2021 4 Holles Natalie C. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $23.25, valued at $581.3k
01/06/2021 4 Holles Natalie C. (Director) has filed a Form 4 on Allakos Inc.
Txns: Granted 4,000 options to buy @ $133.77, valued at $535.1k
12/31/2020 3 Holles Natalie C. (Director) has filed a Form 3 on Allakos Inc.
05/26/2020 4 Holles Natalie C. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $6.22, valued at $155.5k
01/15/2020 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Unknown transaction of 104,439 shares @ $60, valued at $6.3M
Disposed/sold 110,703 options to buy @ $2.7649, valued at $306.1k
Disposed/sold 548 options to buy @ $9.4988, valued at $5.2k
Disposed/sold 40,883 options to buy @ $15.26, valued at $623.9k
Disposed/sold 93,109 options to buy @ $27.39, valued at $2.6M
Disposed/sold 25,000 options to buy @ $36.39, valued at $909.8k
Disposed/sold 50,105 options to buy @ $24.74, valued at $1.2M
12/16/2019 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Paid exercise price by delivering 8,681 shares @ $59.37, valued at $515.4k
Paid exercise price by delivering 88,928 shares @ $59.37, valued at $5.3M
Exercised 45,726 options to buy @ $2.7649, valued at $126.4k
Exercised 5,715 options to buy @ $9.4988, valued at $54.3k
Exercised 74,117 options to buy @ $15.26, valued at $1.1M
Exercised 6,891 options to buy @ $27.39, valued at $188.7k
Exercised 14,895 options to buy @ $24.74, valued at $368.5k
12/09/2019 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Paid exercise price by delivering 505 shares @ $59.21, valued at $29.9k
09/09/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/07/2019 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Paid exercise price by delivering 1,009 shares @ $37.31, valued at $37.6k
04/01/2019 4 Holles Natalie C. (Director) has filed a Form 4 on Rubius Therapeutics, Inc.
Txns: Granted 50,000 options to buy @ $18.1, valued at $905k
03/27/2019 3 Holles Natalie C. (Director) has filed a Form 3 on Rubius Therapeutics, Inc.
02/08/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/25/2019 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Exercised 8,300 options to buy @ $2.7649, valued at $22.9k
06/04/2018 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Exercised 5,090 options to buy @ $2.7649, valued at $14.1k
05/08/2018 4 Holles Natalie C. (President and COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $36.39, valued at $909.8k
11/17/2017 4 Holles Natalie C. (Senior Vice President, COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $27.39, valued at $2.7M
06/01/2017 4 Holles Natalie C. (Senior Vice President, COO) has filed a Form 4 on Audentes Therapeutics, Inc.
Txns: Exercised 20,000 options to buy @ $2.76, valued at $55.2k
01/27/2017 4 Holles Natalie C. (Senior Vice President, COO) has filed a Form 4 on Audentes Therapeutics, Inc.
07/19/2016 3 Holles Natalie C. (Senior Vice President, COO) has filed a Form 3 on Audentes Therapeutics, Inc.
05/08/2015 4 Holles Natalie C. (SVP, Business Development) has filed a Form 4 on HYPERION THERAPEUTICS INC
Txns: Unknown transaction of 702 shares @ $46, valued at $32.3k
Disposed/sold 17,750 shares @ $46, valued at $816.5k
Disposed/sold 63,000 options to buy @ $22.02, valued at $1.4M
Disposed/sold 21,000 options to buy @ $22.06, valued at $463.3k
Disposed/sold 29,000 options to buy @ $26.74, valued at $775.5k
Disposed/sold 24,000 options to buy @ $25.97, valued at $623.3k
02/10/2015 4 Holles Natalie C. (SVP, Business Development) has filed a Form 4 on HYPERION THERAPEUTICS INC
Txns: Granted 14,000 shares @ $0
Granted 24,000 options to buy @ $25.97, valued at $623.3k
01/05/2015 4 Holles Natalie C. (SVP, Business Development) has filed a Form 4 on HYPERION THERAPEUTICS INC
Txns: Paid exercise price by delivering 548 shares @ $24.28, valued at $13.3k
03/13/2014 4 Form 4 - Statement of changes in beneficial ownership of securities
08/19/2013 4 Holles Natalie C. (SVP, Corp & Business Dev) has filed a Form 4 on HYPERION THERAPEUTICS INC
Txns: Granted 21,000 options to buy @ $22.06, valued at $463.3k
07/02/2013 4 Holles Natalie C. (SVP, Corp & Business Dev) has filed a Form 4 on HYPERION THERAPEUTICS INC
Txns: Granted 63,000 options to buy @ $22.02, valued at $1.4M
06/25/2013 3 Holles Natalie C. (SVP, Corp & Business Dev) has filed a Form 3 on HYPERION THERAPEUTICS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy